Story at a glance
- President Biden is planning on sharing U.S.–made AstraZeneca vaccine doses.
- Administration officials say the U.S. is well-stocked in terms of vaccine supply.
- The FDA will review all outgoing shipments.
Speaking during Monday’s White House Press Briefing, Press Secretary Jen Psaki confirmed that the Biden administration plans on sharing its doses of AstraZeneca COVID-19 vaccine with other countries who are still struggling to contain the spread of the disease.
Psaki told reporters that the U.S. government is looking at sharing doses of AstraZeneca made in the U.S. abroad simply because the country is already well-stocked.
“Given the strong portfolio of vaccines that the U.S. has already authorized and that is available in large quantities…and given AstraZeneca is not authorized in the U.S., we do not need to use AstraZeneca in the fight against Covid in the next few months,” she said.
All shipments are slated to occur over the next few months. The U.S. Food and Drug Administration (FDA) will be tasked with reviewing and inspecting shipments of doses prior to being sent abroad.
Psaki did confirm that the administration is in the planning process and will discuss where vaccine supplies are being sent.
One of the newest global hotspots for COVID-19 case outbreaks is in India. President Biden has pledged his administration’s support in providing medical supplies and emergency equipment, and vaccine doses could be included.
PFIZER-BIONTECH BOOSTER LIKELY NEEDED AS IMMUNITY WANES, SAYS SCIENTIST WHO HELPED DEVELOP VACCINE
AFTER CALLING IT A SCAM, CONTROVERSIAL ROCKER TED NUGENT CONTRACTS COVID-19
COMPANY AWARDED MILLIONS BY TRUMP TO MAKE VACCINE SYRINGES HAS NOT MADE EVEN ONE
changing america copyright.
